NCT06860815View on ClinicalTrials.gov

Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

December 12, 2025

Primary Completion Date

January 3, 2027

Study Completion Date

January 3, 2027

Conditions
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Carcinoma in the Liver
Interventions
PROCEDURE

Biopsy

Undergo tumor biopsy

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

BIOLOGICAL

Cemiplimab

Given IV

PROCEDURE

Computed Tomography

Undergo CT

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

RADIATION

Transarterial Radioembolization

Undergo TARE

RADIATION

Yttrium Y 90 Resin Microspheres

Given intratumorally

Trial Locations (1)

91010

RECRUITING

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER